Dr. Beth Faiman Shares Insights From Her Myeloma Presentations at ASH 2024
Dr. Beth Faiman Shares Insights From Her Myeloma Presentations at ASH 2024

Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, of the Cleveland Clinic Taussig Cancer Institute in Ohio, joined Cancer Nursing Today at the 2024 American Society of Hematology Annual Meeting and Exposition to discuss her multiple myeloma research.

She presented multiple abstracts at the meeting, one of which focused on patient experiences with talquetamab, which is a GPRC5D-targeting bispecific antibody for myeloma.

“I think that it's an especially important role for nurses, advanced practitioners, and physicians alike to let patients know what to experience, give them suggestions for side effect management,” Dr. Faiman said.

Advertisement

Latest News

Opinion: Brian Thompson’s Shooting and Why People Are So Angry
Opinion: Brian Thompson’s Shooting and Why People Are So Angry
Theresa Brown, RNNews | December 13, 2024
Theresa Brown, RN, weighs in on the public reaction to the shooting of United Healthcare CEO Brian Thompson.
What Predicts Disease Progression in Myelofibrosis?
What Predicts Disease Progression in Myelofibrosis?
Cecilia BrownConferences | December 13, 2024
An ASH 2024 presentation of data from the Myelofibrosis and Essential Thrombocythemia Observational Study provided insights.
ABA2 Trial Evaluates Addition of Abatacept to GVHD Prophylaxis
ABA2 Trial Evaluates Addition of Abatacept to GVHD Prophylaxis
Katie KoskoGVHD | December 13, 2024
The study highlighted that adding abatacept to CNI/MTX-based GVHD prophylaxis showed durable central outcomes post-HCT.
Expert Reflects on Key GVHD Updates
Expert Reflects on Key GVHD Updates
Kirk R. Schultz, MD, FCAHSGVHD | December 13, 2024
Kirk R. Schultz, MD, FCAHS, explains that multiple strategies for GVHD prevention and preemption are under investigation.
What Predicts GVHD Risk in Patients Receiving PTCy?
What Predicts GVHD Risk in Patients Receiving PTCy?
Katie KoskoConferences | December 13, 2024
Risk factors for GVHD and its severity differ by donor type following allogeneic SCT with post-transplant PTCy prophylaxis.
Smoking Linked With Increased Risk of Chronic Lung GVHD
Smoking Linked With Increased Risk of Chronic Lung GVHD
Katie KoskoGVHD | December 13, 2024
Patients with pulmonary comorbidities and a history of smoking are at increased risk for chronic GVHD.
Prithviraj Bose, MD, on Using Anemia-Supporting Medications With Ruxolitinib for Myelofibrosis
Prithviraj Bose, MD, on Using Anemia-Supporting Medications With Ruxolitinib for Myelofibrosis
Prithviraj Bose, MDConferences | December 13, 2024
Dr. Bose joined Cancer Nursing Today at ASH 2024 to share insights on using anemia-supporting medications with ruxolitinib.
Nursing Management Improves Quality of Life, Mental Health in Elderly Patients With Gastric Cancer
Nursing Management Improves Quality of Life, Mental Health in Elderly Patients With Gastric Cancer
Laura LitwinGI Cancer | December 13, 2024
Intensive nursing management during chemotherapy can greatly improve quality of life in elderly patients with gastric cancer.
Researchers Evaluate Strategy to Prevent Acute GI GVHD
Researchers Evaluate Strategy to Prevent Acute GI GVHD
Piyanuch Kongtim, MD, PhDConferences | December 12, 2024
Piyanuch Kongtim, MD, PhD, shares insights from work she presented at the 2024 ASH Annual Meeting.
Descriptive Survey Reveals Supportive Needs of Informal Caregivers for Elderly Patients With Gastrointestinal Cancer
Descriptive Survey Reveals Supportive Needs of Informal Caregivers for Elderly Patients With Gastrointestinal Cancer
Laura LitwinGI Cancer | December 13, 2024
A recent study highlights the support needed by informal caregivers of elderly patients with gastrointestinal cancer.
What Affects Coping Flexibility in Patients With Gastric Cancer After Gastrectomy?
What Affects Coping Flexibility in Patients With Gastric Cancer After Gastrectomy?
Laura LitwinGI Cancer | December 13, 2024
A new study is highlighting the important role of nursing support after gastrectomy.
Samantha Shenoy, NP, Discusses Key Highlights From ASH 2024
Samantha Shenoy, NP, Discusses Key Highlights From ASH 2024
Samantha Shenoy, NPConferences | December 11, 2024
Samantha Shenoy, NP, speaks about her experience at the meeting and key highlights in multiple myeloma research.
Advertisement
Advertisement
Our Contributors
Theresa Brown, RN
Theresa Brown, RNTheresa Brown, RN, is the New York Times best-selling author of "Healing" and "The Shift."
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Milagros Elia, MA, APRN, ANP-BC
Milagros Elia, MA, APRN, ANP-BCMilagros R. Elia, MA, APRN, ANP-BC, has 25+ years of oncology experience and is a highly regarded activist.
Pamela K. Ginex, EdD, MPH, RN, OCN
Pamela K. Ginex, EdD, MPH, RN, OCNPamela K. Ginex, EdD, MPH, RN, OCN, is an Assistant Professor at the Stony Brook University School of Nursing.
Teresa Hagan Thomas, PhD, RN
Teresa Hagan Thomas, PhD, RNTeresa Hagan Thomas, PhD, RN, is an Assistant Professor at the University of Pittsburgh School of Nursing.
Amanda Brink, DNP, APRN, FNP-BC, AOCNP
Amanda Brink, DNP, APRN, FNP-BC, AOCNPAmanda Brink, DNP, APRN, FNP-BC, AOCNP, is an oncology nurse practitioner at the MD Anderson Cancer Center.
Alicia Michaelsen, BSN, RN, BMTCN®
Alicia Michaelsen, BSN, RN, BMTCN®Alicia Michaelsen, BSN, RN, BMTCN®, is a nurse with over a decade of experience.
Fatemeh Youssefi, PhD, RN, OCN
Fatemeh Youssefi, PhD, RN, OCNFatemeh Youssefi, PhD, RN, OCN, is a nurse who has specialized in oncology for the past 20 years.

Expert Interviews

Conference Highlights

What Predicts Disease Progression in Myelofibrosis?
Cecilia BrownConferences | December 13, 2024
An ASH 2024 presentation of data from the Myelofibrosis and Essential Thrombocythemia Observational Study provided insights.
Read More
ABA2 Trial Evaluates Addition of Abatacept to GVHD Prophylaxis
Katie KoskoGVHD | December 13, 2024
The study highlighted that adding abatacept to CNI/MTX-based GVHD prophylaxis showed durable central outcomes post-HCT.
Read More
What Predicts GVHD Risk in Patients Receiving PTCy?
Katie KoskoConferences | December 13, 2024
Risk factors for GVHD and its severity differ by donor type following allogeneic SCT with post-transplant PTCy prophylaxis.
Read More
Smoking Linked With Increased Risk of Chronic Lung GVHD
Katie KoskoGVHD | December 13, 2024
Patients with pulmonary comorbidities and a history of smoking are at increased risk for chronic GVHD.
Read More

Network Websites

Blood Cancers Today provides hematologists and oncologists with news, education, and research relevant to their patients and practices. Featuring the latest clinical updates from all facets of the specialty, it offers insights and exclusive interviews from experts in the field.

GU Oncology Now delivers the latest news in genitourinary oncology therapeutics, clinical trials, conference coverage, and research data, highlighting important advancements in treatments and technologies to better inform providers' decisions and improve patient outcomes.

DocWire News is a leading source of medical industry news for health care professionals, featuring breaking news, expert commentary, research analysis, and conference highlights. It covers a comprehensive range of clinical specialties, including cardiology, oncology, and more.

MashupMD is an innovative medical news and social media aggregator. The platform is optimized to deliver rapid access to the latest headlines in health care and collections of key medical content based on what health care professionals around the world are reading.

Urban Health Today is the leading independent news source that provides urban health care professionals with relevant research and policy developments that impact patients and their practices. It focuses on clinical, social, and environmental health disparities.

Powered by DocWire News

GI Oncology Now is the leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies, offering the latest study data and research breakthroughs related to colorectal, gastric, liver, pancreatic, and esophageal cancers.

Heme Today produces the latest news and research for hematologists and oncologists focused on blood disorders such as clotting, red and white blood cell, and iron disorders, including conference highlights, late-breaking research, interviews with leaders in the field, and more.

A medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and data analysis to inform providers on the latest research and most effective clinical practices in the lung cancers space.

Nephrology Times delivers the latest news in nephrological treatments and technologies, curating content from clinical trials, conference highlights, and perspectives from key opinion leaders, with the goal of better informing care decisions and improving patient outcomes.

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • Connect

    eNewsletters

    Contact Us

    Contribute

    Calendar of Events

    Our Network

    Blood Cancers Today

    GU Oncology Now

    DocWire News

    MashupMD

    Urban Health Today

    About Us

    About Us

    Editorial Policy

    Authors

    Advertising

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy